ライフサイエンスコーパス: estimated glomerular filtration rate

1 preoperative serum creatinine value or a low estimated glomerular filtration rate).

2 aths, and 698 outcomes of >/= 30% decline in estimated glomerular filtration rate.

3 adjusting for age, sex, body mass index, and estimated glomerular filtration rate.

4 survival, and renal function, as assessed by estimated glomerular filtration rate.

5 omposite end point of ESRD or halving of the estimated glomerular filtration rate.

6 d 13 (65%) had a significant decrease in the estimated glomerular filtration rate.

7 ystem, stratified by HbA1c, BMI, region, and estimated glomerular filtration rate.

8 ating renal function, regardless of baseline estimated glomerular filtration rate.

9 tory of smoking, elevated triglycerides, and estimated glomerular filtration rate.

10 k profiles, including the entire spectrum of estimated glomerular filtration rates.

11 nsplant, SLK and LAT patients had comparable estimated glomerular filtration rates.

12 on in creatinine clearance (median change in estimated glomerular filtration rate -1.8 mL/min [IQR -7

13 mer in 306 outpatients with type 2 diabetes (estimated glomerular filtration rate, 15 to <60 mL/min/1

14 ion, without cirrhosis and with CKD stage 4 (estimated glomerular filtration rate, 15-30 mL/min/1.73

15 ed by 30% after nephrectomy (absolute change estimated glomerular filtration rate 28 +/- 6.9 and 27 +

16 ith mild to moderate chronic kidney disease (estimated glomerular filtration rates, 30-60 mL/min per

17 ssover feeding study in 11 CKD participants (estimated glomerular filtration rate: 30-45 mL . min(-1)

18 eater (1.5+/-0.7 vs. 1.0+/-0.9; P=0.003) and estimated glomerular filtration rate (49.5+/-17.4 vs. 60

19 Overall, 1461 (10%) had CKD (mean [SD] estimated glomerular filtration rate, 49 [10] mL/min/1.7

20 initial hospital stay, patient survival, and estimated glomerular filtration rate 6, 12, 36, and 60 m

21 duction group had the highest average 1-year estimated glomerular filtration rate (62 mL/min/1.73 kg/

22 emergency status, transfer status, baseline estimated glomerular filtration rate, admission APACHE s

23 If censored for primary nonfunction, estimated glomerular filtration rates after 1 year and 5

24 first 2 days after admission and related to estimated glomerular filtration rate, age, history of di

25 diastolic blood pressure, HbA1c, treatment, estimated glomerular filtration rate, albumin-to-creatin

26 tment for established risk factors including estimated glomerular filtration rate, an elevated SDMA-l

27 he R group showed a 1.5-fold higher level of estimated glomerular filtration rate and a fourfold lowe

28 Changes in the estimated glomerular filtration rate and albuminuria wer

29 Posttransplant outcomes included 1-year estimated glomerular filtration rate and death-censored

30 cidences of >50% reduction in their baseline estimated glomerular filtration rate and end stage kidne

31 Black veterans with normal estimated glomerular filtration rate and equal access to

32 Serial changes in estimated glomerular filtration rate and in serum potass

33 often used in those with higher BMI, higher estimated glomerular filtration rate and lower creatinin

34 Estimated glomerular filtration rate and proteinuria are

35 Patients with both low estimated glomerular filtration rate and proteinuria had

36 oring in primary care, serum creatinine with estimated glomerular filtration rate and proteinuria mea

37 was no significant association between eGFR (estimated glomerular filtration rate) and serum sclerost

38 d based on baseline UACR and renal function (estimated glomerular filtration rate), and then randomly

39 patients (n = 50) matched for age, sex, and estimated glomerular filtration rate, and 23 renal trans

40 at short-term follow-up, 1 had a normalized estimated glomerular filtration rate, and 3 (4%) had per

41 In contrast, blood pressure lowering, estimated glomerular filtration rate, and albuminuric ef

42 A1c), blood urea nitrogen, serum creatinine, estimated glomerular filtration rate, and blood chemistr

43 ase (n = 110) who were matched for age, sex, estimated glomerular filtration rate, and date of MR ima

44 ase assessment should have serum creatinine, estimated glomerular filtration rate, and electrolytes m

45 s were younger, with higher body mass index, estimated glomerular filtration rate, and forced expirat

46 e, sex, hypertension, smoking, sodium level, estimated glomerular filtration rate, and high-sensitivi

47 erminal pro-brain natriuretic peptide, lower estimated glomerular filtration rate, and larger left at

48 de level, fibroblast growth factor 23 level, estimated glomerular filtration rate, and proteinuria, t

49 um, serum albumin, high-density lipoprotein, estimated glomerular filtration rate, and QTc interval.

50 We then compared the development of DM, the estimated glomerular filtration rate, and the level of a

51 y beta2M, urinary protein, serum creatinine, estimated glomerular filtration rate, and/or pyuria were

52 oups had comparable serum creatinine levels, estimated glomerular filtration rates, and daily urine o

53 rol to high-density lipoprotein cholesterol, estimated glomerular filtration rate, antihypertensive t

54 sex, intermittent claudication, heart rate, estimated glomerular filtration rate, apolipoprotein B/a

55 lement intake, smoking, and kidney function (estimated glomerular filtration rate) as additional pred

56 al, incidence of delayed graft function, and estimated glomerular filtration rate at 1 and 5 years.

57 ncreased allograft fibrosis and with reduced estimated glomerular filtration rate at 12 months after

58 aired graft function had significantly lower estimated glomerular filtration rate at 12 months postbi

59 f acute or chronic rejection, or in the mean estimated glomerular filtration rate at 15 years.

60 The changes in serum potassium and estimated glomerular filtration rate at 24, 48, 72, and

61 en group differences in patient survival and estimated glomerular filtration rate at any time point.

62 ciated with delayed graft function and lower estimated glomerular filtration rate at end follow-up.

63 The average estimated glomerular filtration rate at hemodialysis ini

64 Patients with lower estimated glomerular filtration rate at prophylaxis cess

65 In this subpopulation, estimated glomerular filtration rates at randomization w

66 ney disease stages 3-5 (ie, patients with an estimated glomerular filtration rate below 60 mL/min per

67 quivalent (beta, 0.70; P < .001), and higher estimated glomerular filtration rate (beta, 0.03; P = .0

68 loss, renal function decline (>20% decrease estimated glomerular filtration rate between 6 months an

69 ve days 3 and 30, there was no difference in estimated glomerular filtration rate between the RF stud

70 d with an acute, dose-dependent reduction in estimated glomerular filtration rate by approximately 5

71 At follow- up, estimated glomerular filtration rate by the Modification

72 nontreated, respectively) and similar across estimated glomerular filtration rate categories but was

73 RCV (0.58 with creatine clearance, 0.54 with estimated glomerular filtration rate-Cockcroft-Gault).

74 Group II showed better outcomes with a mean estimated glomerular filtration rate decline of 6.4 mL/m

75 APOL1-associated estimated glomerular filtration rate decline was observe

76 ease: dialysis, transplantation, and/or >60% estimated glomerular filtration rate decline, or mortali

77 s, which tended to correlate with subsequent estimated glomerular filtration rate decline.

78 Estimated glomerular filtration rate decreased after eac

79 From randomization to month 36, mean (SD) estimated glomerular filtration rate decreased by 7.0 (3

80 the effect of lithium maintenance therapy on estimated glomerular filtration rate (eFGR) in patients

81 in-to-creatinine ratio >/=300 mg/g), reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.

82 tus, established cardiovascular disease, and estimated glomerular filtration rate (eGFR) >/=30 mL.min

83 METHODS AND Among 3 570 865 US veterans with estimated glomerular filtration rate (eGFR) >/=60 mL min

84 s with preserved kidney function (defined by estimated glomerular filtration rate (eGFR) >60 mL/minut

85 Proteinuria >5 g/24 h and estimated glomerular filtration rate (eGFR) <50 mL/min p

86 , or biochemistry and defining CKD as either estimated glomerular filtration rate (eGFR) <60 ml/min/1

87 CKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/p

88 teinuria; whereas positively associated with estimated glomerular filtration rate (eGFR) (all P < 0.0

89 .09, 95% CI: 1.99-4.80), moderately impaired estimated glomerular filtration rate (eGFR) (HR = 1.76,

90 The usefulness of estimated glomerular filtration rate (eGFR) and albuminu

91 h as creatinine level and cystatin C-derived estimated glomerular filtration rate (eGFR) and assessme

92 nderwent transplant kidney biopsy, and their estimated glomerular filtration rate (eGFR) and BK PCR w

93 were to describe serial post-MCS changes in estimated glomerular filtration rate (eGFR) and determin

94 reserved Ejection Fraction) trial, change in estimated glomerular filtration rate (eGFR) and developm

95 The effects of MRP inhibitors on the estimated glomerular filtration rate (eGFR) and proximal

96 on are associated with future decline in the estimated glomerular filtration rate (eGFR) and with inc

97 nd to associate with serum creatinine (SCr), estimated glomerular filtration rate (eGFR) and/or CKD.

98 d biopsy score was used to predict recipient estimated glomerular filtration rate (eGFR) at 1 year.

99 determine the independent association of the estimated glomerular filtration rate (eGFR) by the Chron

100 r for graft survival, whereas one-year graft estimated glomerular filtration rate (eGFR) correlated w

101 els were used to estimate the annual rate of estimated glomerular filtration rate (eGFR) decline, com

102 Urinary albumin and estimated glomerular filtration rate (eGFR) defined kidn

103 Estimated glomerular filtration rate (eGFR) has been rep

104 eta-analysis of kidney function based on the estimated glomerular filtration rate (eGFR) in 110,517 E

105 long-term PM2.5 exposure was associated with estimated glomerular filtration rate (eGFR) in a cohort

106 The mean estimated glomerular filtration rate (eGFR) increased ov

107 lished cerebrovascular disease and preserved estimated glomerular filtration rate (eGFR) is not estab

108 Individuals with >/=2 estimated glomerular filtration rate (eGFR) measurements

109 y disease (stages 3 and 4) was defined as an estimated glomerular filtration rate (eGFR) of 15 to 59

110 r without compensated cirrhosis, and with an estimated glomerular filtration rate (eGFR) of 40 mL/min

111 r without compensated cirrhosis, and with an estimated glomerular filtration rate (eGFR) of 40 mL/min

112 6662 participants with a baseline estimated glomerular filtration rate (eGFR) of at least

113 , and CO concentrations and risk of incident estimated glomerular filtration rate (eGFR) of less than

114 onal cohort of 3,376,187 US veterans with an estimated glomerular filtration rate (eGFR) of more than

115 ohorts of patients with a prehospitalization estimated glomerular filtration rate (eGFR) of more than

116 sing CYP3A and causes reversible declines in estimated glomerular filtration rate (eGFR) owing to inh

117 therapy, linear piecewise regression models estimated glomerular filtration rate (eGFR) slopes befor

118 ociation between the AMS and post-transplant estimated glomerular filtration rate (eGFR) using mixed

119 ild's age of 6 y, we assessed kidney volume, estimated glomerular filtration rate (eGFR) using serum

120 ts of Anti-HIV Drugs (D:A:D) study with >/=3 estimated glomerular filtration rate (eGFR) values after

121 e female, 166 (73.1%) had diabetes, the mean estimated glomerular filtration rate (eGFR) was 33.9 +/-

122 ned for hepatitis B virus (HBV) coinfection, estimated glomerular filtration rate (eGFR) was 50-90 mL

123 Estimated glomerular filtration rate (eGFR) was evaluate

124 Median estimated glomerular filtration rate (eGFR) was lower in

125 Estimated glomerular filtration rate (eGFR) was recorded

126 The change of estimated glomerular filtration rate (eGFR) with off-tre

127 to identify the association of pre-operative estimated glomerular filtration rate (eGFR) with PPCs in

128 71,638 individuals from four ancestries, for estimated glomerular filtration rate (eGFR), a measure o

129 proportional hazard model adjusted for age, estimated glomerular filtration rate (eGFR), and cardiov

130 Plasma NGAL, estimated glomerular filtration rate (eGFR), and cystati

131 raft function/primary nonfunction (DGF/PNF), estimated glomerular filtration rate (eGFR), and graft-s

132 ), hemoglobin, total white cell count (WCC), estimated glomerular filtration rate (eGFR), and liver f

133 r underwent dialysis or not, had an abnormal estimated glomerular filtration rate (eGFR), and underwe

134 y on the recipient's SCr and calculations of estimated glomerular filtration rate (eGFR), based on re

135 After controlling for estimated glomerular filtration rate (eGFR), body mass i

136 lysis of genome-wide association studies for estimated glomerular filtration rate (eGFR), combining d

137 fects on 4 renal outcomes: >/=30% decline in estimated glomerular filtration rate (eGFR), doubling of

138 ired kidney function, as measured by reduced estimated glomerular filtration rate (eGFR), has been as

139 ondary outcomes were HbA1c, LDL cholesterol, estimated glomerular filtration rate (eGFR), incident mi

140 gnificant inverse correlation between CI and estimated glomerular filtration rate (eGFR), such that h

141 Albuminuria, but not estimated glomerular filtration rate (eGFR), was associa

142 ,531 HCV(-) US veterans with normal baseline estimated glomerular filtration rate (eGFR), we examined

143 C, and allograft function, determined by the estimated glomerular filtration rate (eGFR), were assess

144 ociations of coffee and tea consumption with estimated glomerular filtration rate (eGFR).

145 and macroalbuminuria) and rate of change of estimated glomerular filtration rate (eGFR).

146 clinically relevant decline (>/=25%) in the estimated glomerular filtration rate (eGFR).

147 tially normal renal function, as measured by estimated glomerular filtration rate (eGFR).

148 s have used cystatin C-based measures of the estimated glomerular filtration rate (eGFR).

149 ct modification by body mass index (BMI) and estimated glomerular filtration rate (eGFR).

150 c kidney disease (CKD) is defined by reduced estimated glomerular filtration rate (eGFR).

151 hotopic liver transplantation (OLT) based on estimated glomerular filtration rate (eGFR).

152 disease stages were classified according to estimated glomerular filtration rate (eGFR).

153 40L was directly associated with declines in estimated glomerular filtration rate (eGFR).

154 n 1 dialysis session for predicting 12-month estimated glomerular filtration rate (eGFR).

155 Estimated glomerular filtration rate (eGFR, a marker of

156 ans with and without hypertension and normal estimated glomerular filtration rates (eGFR) during 2005

157 Patients with stage 2 CKD (estimated glomerular filtration rate [eGFR] >/=60 to <90

158 ssion as the absence of diagnostic criteria (estimated glomerular filtration rate [eGFR] >60 ml/min/1

159 of patients with baseline renal impairment (estimated glomerular filtration rate [eGFR] </= 60 mL/mi

160 ic kidney disease (CKD, defined as confirmed estimated glomerular filtration rate [eGFR] </= 60 ml/mi

161 We compared prevalence of renal impairment (estimated glomerular filtration rate [eGFR] <60 mL/min/1

162 and chronic kidney disease (serum creatinine estimated glomerular filtration rate [eGFR] <90 mL/min/1

163 s of two measures of chronic kidney disease (estimated glomerular filtration rate [eGFR] and albuminu

164 ine measured in grams] and a decrease in the estimated glomerular filtration rate [eGFR] of <5 ml per

165 Primary outcomes were CKD (defined as an estimated glomerular filtration rate [eGFR] of <60 mL/mi

166 id conditions, serum lipids, renal function (estimated glomerular filtration rate [eGFR]), and educat

167 with stage 1-2 chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR], >/= 60 mL/m

168 Renal dysfunction was categorized as mild (estimated glomerular filtration rate [eGFR], 60-89 mL/mi

169 The estimated slopes of estimated glomerular filtration rate(eGFR) in patients w

170 ated kidney and postdonation renal function (estimated glomerular filtration rate, eGFR) of the remai

171 riable model independent of creatinine-based estimated glomerular filtration rate (eGFRcr).

172 type 2 diabetes mellitus and inversely with estimated glomerular filtration rate (eGFRcreatcysC)(all

173 ey function was measured by cystatin C-based estimated glomerular filtration rate (eGFRcys).

174 Estimated glomerular filtration rate (eGRF) was inversel

175 actors, high-sensitivity C-reactive protein, estimated glomerular filtration rate, elevated TMAO leve

176 Median 1-year estimated glomerular filtration rate for DBD donor kidne

177 The adjusted change in mean estimated glomerular filtration rate from baseline to mo

178 were significant for death, 25% decrease in estimated glomerular filtration rate from baseline, majo

179 in/1.73 m2 (95% CI 0.003-0.02; p < 0.005) in estimated glomerular filtration rate from serum creatini

180 29 (58%) and 51 (51%), respectively, had an estimated glomerular filtration rate (GFR) <50 mL/minute

181 associated with the development of sustained estimated glomerular filtration rate (GFR) <60 mL/min/1.

182 ft ventricular ejection fraction </=45%, and estimated glomerular filtration rate (GFR) 30 to 89 mL/m

183 the annualized changes from baseline in the estimated glomerular filtration rate (GFR) and measured

184 n total kidney volume and the decline in the estimated glomerular filtration rate (GFR) but also caus

185 a hospitalization stratified by tertiles of estimated glomerular filtration rate (GFR).

186 s with ADPKD (15 to 49 years of age, with an estimated glomerular filtration rate [GFR] >60 ml per mi

187 patients, 18 to 64 years of age, with ADPKD (estimated glomerular filtration rate [GFR], 25 to 60 ml

188 Kidney transplantation patients with estimated glomerular filtration rate greater than 90 hav

189 k and 2 525 525 white patients with baseline estimated glomerular filtration rate >/= 60 mL.min(-)(1)

190 er adjusted mortality among individuals with estimated glomerular filtration rate >/= 60 mL.min(-)(1)

191 ghty-five percent of the participants had an estimated glomerular filtration rate >30 mL/min per 1.73

192 We selected adult subjects with an estimated glomerular filtration rate >60 mL/min/1.73m(2)

193 WRF defined as a decrease in estimated glomerular filtration rate>20% or >30% from ba

194 tions were higher in the presence of a lower estimated glomerular filtration rate, higher albuminuria

195 raction, older age, diabetes mellitus, lower estimated glomerular filtration rate, higher heart rate,

196 models, lower systolic blood pressure, lower estimated glomerular filtration rate, higher N-terminal

197 e curve, 0.82; P<0.01), and predicted 14-day estimated glomerular filtration rate in linear regressio

198 formula should be used for the evaluation of estimated glomerular filtration rate in patients with st

199 ant IL-4; whereas positively associated with estimated glomerular filtration rate in patients.

200 Cortical ADCT values correlated with estimated glomerular filtration rate in recipients (R =

201 function at 3 years posttransplant (loss of estimated glomerular filtration rate in the chemoprophyl

202 nths, systolic blood pressure decreased, and estimated glomerular filtration rate increased (P=0.003)

203 cement therapy discontinuation when baseline estimated glomerular filtration rate is above 44 mL/min/

204 ystolic blood pressure, BMI, smoking status, estimated glomerular filtration rate, LDL-cholesterol co

205 tional hazards models adjusted for age, sex, estimated glomerular filtration rate, left ventricular e

206 ohol use, daily blocks walked, diuretic use, estimated glomerular filtration rate, left ventricular m

207 ere highest on admission and were related to estimated glomerular filtration rate, left ventricular w

208 Patients with estimated glomerular filtration rate less than 15 mL/min

209 point was defined as a return to dialysis or estimated glomerular filtration rate less than 15 mL/min

210 Those with baseline estimated glomerular filtration rate less than 15 mL/min

211 atients with end-stage nonrenal disease with estimated glomerular filtration rate less than 30 mL/min

212 ndently associated with the prevalence of an estimated glomerular filtration rate less than 30 mL/min

213 Patients with mean baseline estimated glomerular filtration rate less than 45 mL/min

214 asked hypertension, 32% had LVH, and 38% had estimated glomerular filtration rate less than 60 mL/min

215 er than 3.0 mg/dL, cystatin C >/=1.11 mg/dL, estimated glomerular filtration rate less than 60 mL/min

216 -two transplants and 97 CKD patients with an estimated glomerular filtration rate less than 60 mL/min

217 ed adults with type 2 diabetes and CKD (with estimated glomerular filtration rate less than 60 mL/min

218 Chronic kidney disease was defined as estimated glomerular filtration rate less than 60 mL/min

219 The outcome was incident CKD, defined as an estimated glomerular filtration rate less than 60 mL/min

220 atment of adults aged 50 years or older with estimated glomerular filtration rates less than 60 mL/mi

221 mutation after adjusting for age, race, sex, estimated glomerular filtration rate, liver volume, and

222 uld be considered if chronic kidney disease (estimated glomerular filtration rate < 45 mL/min/1.73 m(

223 heart failure had previous heart failure, an estimated glomerular filtration rate </=60 mL/min, or el

224 of stroke, >1 g proteinuria, heart failure, estimated glomerular filtration rate <20 mL.min(-1).1.73

225 in 24 h of proteinuria daily, heart failure, estimated glomerular filtration rate <20 ml/min/1.73 m(2

226 dney disease, renal death, development of an estimated glomerular filtration rate <30 mL/min per 1.73

227 al contraindicated AHM use for patients with estimated glomerular filtration rate <30 mL/min/1.73m(2)

228 Among 1512 patients with estimated glomerular filtration rate <30 mL/min/1.73m(2)

229 ontrast group had borderline renal function (estimated glomerular filtration rate <45 mL/min/1.73 m(2

230 ted in patients with chronic kidney disease (estimated glomerular filtration rate <60 mL.min(-1).1.73

231 ned as Modification of Diet in Renal Disease-estimated glomerular filtration rate <60 mL.min(-1).1.73

232 atients and by 28% in patients with baseline estimated glomerular filtration rate <60 mL/min per 1.73

233 ns participants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min per 1.73

234 y artery disease and chronic kidney disease (estimated glomerular filtration rate <60 mL/min).

235 In a post hoc analysis of subjects with an estimated glomerular filtration rate <60 ml/min/1.73 m(2

236 active dyspnea, and any of the following: 1) estimated glomerular filtration rate <60 ml/min/1.73 m(2

237 d hs-cTnI in patients with RD, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2

238 al worsening within 1 year in ACHD included: estimated glomerular filtration rate <60 ml/min/1.73 m(2

239 se participants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2)

240 The main outcome was CKD, defined as estimated glomerular filtration rate <60 mL/minute/1.73

241 in those with and without renal impairment (estimated glomerular filtration rate <60mL/min/1.73m(2))

242 Low estimated glomerular filtration rate (<40 mL/min/1.73 m(

243 on rate, 15-30 mL/min/1.73 m(2)) or stage 5 (estimated glomerular filtration rate, <15 mL/min/1.73 m(

244 r follow-up in 521 stable subjects with CKD (estimated glomerular filtration rate, <60 mL/min per 1.7

245 atients with active/acute ABMR had a 3-month estimated glomerular filtration rate (median,: 43 mL/min

246 tal and low-density lipoprotein cholesterol, estimated glomerular filtration rate, metabolic syndrome

247 blood pressure, lipid profile, retinopathy, estimated glomerular filtration rate, (micro)albuminuria

248 eath-censored) renal allograft survival with estimated glomerular filtration rates (mL/min per 1.73 m

249 acute rejection or severe graft dysfunction: estimated glomerular filtration rate (Modification of Di

250 Estimated glomerular filtration rates (Modification of D

251 All of the patients had an estimated glomerular filtration rate more than 60 mL/min

252 functional class, diastolic blood pressure, estimated glomerular filtration rate, N-terminal pro-B-t

253 CVD risk (history of coronary heart disease, estimated glomerular filtration rate of 20 to 59 ml/min/

254 ciency Cohort study recruited adults with an estimated glomerular filtration rate of 20 to 70 mL/min/

255 n to creatinine ratio [UACR] 100-3000 mg/g), estimated glomerular filtration rate of 25 mL/min per 1.

256 Patients with pre-existing estimated glomerular filtration rate of 30 mL/min/1.73 m

257 R], 1.26; 95% CI, 1.05-1.51) and decrease in estimated glomerular filtration rate of 30% or more (11,

258 ned as doubling of creatinine or decrease in estimated glomerular filtration rate of 30% or more.

259 the time of transplant, HRS2 patients had an estimated glomerular filtration rate of 41 +/- 1 mL/min

260 ressed (HIV-1 RNA <50 copies per mL) with an estimated glomerular filtration rate of 50 mL per min or

261 tenofovir, lamivudine, and abacavir; and an estimated glomerular filtration rate of 50 mL/min or mor

262 Allograft function was excellent with a mean estimated glomerular filtration rate of 54 mL per min af

263 r undergoing cardiac catheterisation with an estimated glomerular filtration rate of 60 mL/min per 1.

264 ded no history of virological failure and an estimated glomerular filtration rate of 70 mL per min or

265 ced decline of graft function (difference in estimated glomerular filtration rate of 9.6 mL/min per 1

266 ven among those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73 m

267 ssigned patients with type 2 diabetes and an estimated glomerular filtration rate of at least 30 ml p

268 adults (HIV-1 RNA >/=500 copies per mL) with estimated glomerular filtration rate of at least 30 mL/m

269 CD4 count of at least 100 cells per muL, and estimated glomerular filtration rate of at least 90 mL/m

270 D+/R- serostatus (vs. R+ serostatus) and an estimated glomerular filtration rate of less than 45 mL/

271 L, CD4 counts of at least 200 cells per muL, estimated glomerular filtration rates of at least 70 mL

272 outcome of a reduction of 50% or more in the estimated glomerular filtration rate or end-stage graft

273 here was no significant difference in 1-year estimated glomerular filtration rate or graft failure be

274 (63.6%) compared with those with either low estimated glomerular filtration rate or proteinuria (18.

275 nce in patient or graft survival, rejection, estimated glomerular filtration rate, or other adverse e

276 riate analysis, serum uric acid (P = 0.001), estimated glomerular filtration rate (P = 0.027), and VC

277 In addition to baseline clinical variables (estimated glomerular filtration rate, previously documen

278 * was found to be negatively correlated with estimated glomerular filtration rate (R = -0.47, P < .00

279 Estimated glomerular filtration rate remained lower in g

280 tion and a renal composite (40% reduction in estimated glomerular filtration rate, renal replacement

281 included NYHA functional class (III vs. II), estimated glomerular filtration rate, responders to chem

282 outcome of a sustained 40% reduction in the estimated glomerular filtration rate, the need for renal

283 0.001), as well as following the addition of estimated glomerular filtration rate to the model (HR: 1

284 ants was 67 y, 52% were female, and the mean estimated glomerular filtration rate was 31 +/- 9 mL . m

285 (28%) had type 2 diabetes mellitus, the mean estimated glomerular filtration rate was 85 (SD 19) mL/m

286 le a 1-U increase in spherical equivalent or estimated glomerular filtration rate was associated with

287 Estimated glomerular filtration rate was calculated usin

288 atinine were measured prospectively, and the estimated glomerular filtration rate was calculated.

289 No change in estimated glomerular filtration rate was noted after the

290 r the ABMR treatment, a 16-mL/min decline in estimated glomerular filtration rate was observed in pat

291 r, after 3 months, a progressively declining estimated glomerular filtration rate was observed more f

292 Estimated glomerular filtration rate was obtained before

293 Baseline estimated glomerular filtration rate was the only one pr

294 , the patient's weight, BMI, creatinine, and estimated glomerular filtration rate were 81.9 kg, 35.1

295 ailure, graft and patient survival, and mean estimated glomerular filtration rate were also comparabl

296 e, stroke, mortality, and >/= 30% decline in estimated glomerular filtration rate were examined using

297 score, interstitial inflammation score, and estimated glomerular filtration rate were significantly

298 rise in serum potassium and (2) reduction in estimated glomerular filtration rate when compared with

299 In MESA, an association of low estimated glomerular filtration rate with incident AF wa

300 derate chronic kidney disease, as defined by estimated glomerular filtration rate, with appropriate d